Upsher-Smith launches generic Tapazole
Methimazole had a market value of roughly $36.8 million for the 12 months ending December 2023, per IQVIA.
Upsher-Smith is offering Methimazole Tablets, 5 mg and 10 mg, which is the generic of King Pharmaceuticals’ Tapazole. It is indicated:
- In patients with Graves' disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option.
- To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.
[Read more: Upsher-Smith, NASPA recognize 47 pharmacists with 2022 NASPA Excellence in Innovation Award]
Methimazole had a market value of roughly $36.8 million for the 12 months ending December 2023, per IQVIA.